CALA (Calithera Biosciences) Total Operating Expense: $42.07 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Total Operating Expense?

Calithera Biosciences CALA Total Operating Expense is $42.07 Mil as of Dec. 2022.

Calithera Biosciences's Total Operating Expense for the three months ended in Dec. 2022 was $7.35 Mil. Calithera Biosciences's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 was $42.07 Mil.

Calithera Biosciences Total Operating Expense Related Terms

Calithera Biosciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Total Operating Expense Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.54 92.90 91.39 74.31 42.07

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 13.83 11.38 9.53 7.35

Calithera Biosciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $42.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $42.07 Mil mean?
Calithera Biosciences (CALA) has a Total Operating Expense of $42.07 Mil as of Dec. 2022. Total operating expense is the primary recurring expense associated with central operations. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Total Operating Expense too high?
Calithera Biosciences' current Total Operating Expense is $42.07 Mil.
How does Calithera Biosciences' Total Operating Expense compare to PPCB and QBIO?
Calithera Biosciences' Total Operating Expense of $42.07 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Diversified Financial Services company?
A good Total Operating Expense depends on the Diversified Financial Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Total Operating Expense is $42.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Total Operating Expense of $42.07 Mil. The current Total Operating Expense is $42.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Total Operating Expense is $42.07 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.